Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Signoriello

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Antioxidants (Basel, Switzerland)|March 28, 2026
Intake of the Total, Classes, and Subclasses of (Poly)phenols and Breast Cancer Risk: A Prospective Analysis of the EPIC StudyMaría Fernanda López-Padilla, David Seoane-Miraz, Daniel Guiñón-Fort, et al.
Gynecologic Oncology|April 14, 2019
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancerSandro Pignata, Giovanni Scambia, Domenica Lorusso, et al.
Cancers|October 23, 2021
Evaluation of Angiogenesis-Related Genes as Prognostic Biomarkers of Bevacizumab Treated Ovarian Cancer Patients: Results from the Phase IV MITO16A/ManGO OV-2 Translational StudyDaniela Califano, Daniela Gallo, Gian Luca Rampioni Vinciguerra, et al.
Frontiers in Nutrition|September 19, 2022
Adherence to mediterranean diet and the risk of differentiated thyroid cancer in a European cohort: The EPIC studyFjorida Llaha, Valerie Cayssials, Marta Farràs, et al.
British Journal of Cancer|January 15, 2022
Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancerTrasias Mukama, Renée Turzanski Fortner, Verena Katzke, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Antioxidants (Basel, Switzerland)|March 28, 2026
Intake of the Total, Classes, and Subclasses of (Poly)phenols and Breast Cancer Risk: A Prospective Analysis of the EPIC StudyMaría Fernanda López-Padilla, David Seoane-Miraz, Daniel Guiñón-Fort, et al.
Gynecologic Oncology|April 14, 2019
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancerSandro Pignata, Giovanni Scambia, Domenica Lorusso, et al.
Cancers|October 23, 2021
Evaluation of Angiogenesis-Related Genes as Prognostic Biomarkers of Bevacizumab Treated Ovarian Cancer Patients: Results from the Phase IV MITO16A/ManGO OV-2 Translational StudyDaniela Califano, Daniela Gallo, Gian Luca Rampioni Vinciguerra, et al.
Frontiers in Nutrition|September 19, 2022
Adherence to mediterranean diet and the risk of differentiated thyroid cancer in a European cohort: The EPIC studyFjorida Llaha, Valerie Cayssials, Marta Farràs, et al.
British Journal of Cancer|January 15, 2022
Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancerTrasias Mukama, Renée Turzanski Fortner, Verena Katzke, et al.
Pageof 6